340 related articles for article (PubMed ID: 7569948)
1. Confirmation for combination AIDS therapy.
Science; 1995 Oct; 270(5233):33. PubMed ID: 7569948
[No Abstract] [Full Text] [Related]
2. Other AIDS drug regimens beat AZT alone, reduce clinical progression and mortality.
Stephenson J
JAMA; 1995 Oct; 274(15):1183-4. PubMed ID: 7563492
[No Abstract] [Full Text] [Related]
3. AZT combination trial shows positive results.
Nature; 1995 Sep; 377(6547):277. PubMed ID: 7566074
[No Abstract] [Full Text] [Related]
4. Study results at a glance.
AIDS Alert; 1995 Nov; 10(11):134. PubMed ID: 11362922
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral drugs: new agents, new combinations line up against HIV.
Phillips L
Hosp Technol Ser; 1996 Jan; 15(1):1-3. PubMed ID: 10161344
[No Abstract] [Full Text] [Related]
6. Making sense of 175 and Delta.
Smart T
GMHC Treat Issues; 1995 Oct; 9(10):4. PubMed ID: 11362916
[TBL] [Abstract][Full Text] [Related]
7. Studies of zidovudine in combination with didanosine and zalcitabine.
Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
[TBL] [Abstract][Full Text] [Related]
8. [AIDS therapy with reverse transcriptase inhibitors].
Mitsuya H
Nihon Rinsho; 1993 Sep; 51 Suppl():316-26. PubMed ID: 7505849
[No Abstract] [Full Text] [Related]
9. Therapy for human immunodeficiency virus infection -- what have we learned?
Corey L; Holmes KK
N Engl J Med; 1996 Oct; 335(15):1142-4. PubMed ID: 8813046
[No Abstract] [Full Text] [Related]
10. ACTG 175 and Delta.
Torres G
GMHC Treat Issues; 1995 Oct; 9(10):2-3. PubMed ID: 11362915
[TBL] [Abstract][Full Text] [Related]
11. New developments in antiretroviral drug therapy for HIV infection.
Johnson VA
AIDS Clin Rev; 1992; ():69-104. PubMed ID: 1318738
[No Abstract] [Full Text] [Related]
12. Studies confirm value of early and combination treatments.
Vazquez E
Posit Aware; 1995; VI(6):8. PubMed ID: 11363148
[TBL] [Abstract][Full Text] [Related]
13. [Anti-HIV therapy (1987-1994): from nothing to confusion].
Lissen E
Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
[No Abstract] [Full Text] [Related]
14. HIV's Achilles' heel. Drugs and education are starting to slow the AIDS virus.
Beardsley T
Sci Am; 1996 Sep; 275(3):16, 18. PubMed ID: 8701287
[No Abstract] [Full Text] [Related]
15. New developments in antiretroviral drug therapy for HIV-1 infections.
Johnson VA
AIDS Clin Rev; 1995-1996; ():305-46. PubMed ID: 7488558
[No Abstract] [Full Text] [Related]
16. New trials reach same conclusion: two drugs are better than AZT alone.
AIDS Alert; 1995 Nov; 10(11):133-6. PubMed ID: 11362921
[TBL] [Abstract][Full Text] [Related]
17. Zidovudine and other reverse transcriptase inhibitors in the management of human immunodeficiency virus-related disease.
Matthews SJ; Cersosimo RJ; Spivack ML
Pharmacotherapy; 1991; 11(6):419-48; discussion 448-9. PubMed ID: 1722897
[TBL] [Abstract][Full Text] [Related]
18. Treatment of late-state HIV infection.
Millard PS
J Fam Pract; 1997 Feb; 44(2):132-4. PubMed ID: 9040512
[No Abstract] [Full Text] [Related]
19. FDA expands testing of anti-AIDS drugs.
N Y State J Med; 1989 Sep; 89(9):548. PubMed ID: 2552360
[No Abstract] [Full Text] [Related]
20. A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.
Henry K; Erice A; Tierney C; Balfour HH; Fischl MA; Kmack A; Liou SH; Kenton A; Hirsch MS; Phair J; Martinez A; Kahn JO
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):339-49. PubMed ID: 9833742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
